Extracellular vesicle-based formulation of doxorubicin: drug loading optimization, characterization, and cytotoxicity evaluation in tumor spheroids-Reference-Cited by-同舟云学术

Extracellular vesicle-based formulation of doxorubicin: drug loading optimization, characterization, and cytotoxicity evaluation in tumor spheroids

Published:2024-08-06 Issue:7 Volume:29 Page:727-737
ISSN:1083-7450
Container-title:Pharmaceutical Development and Technology
language:en
Short-container-title:Pharmaceutical Development and Technology

Author:

Mehryab Fatemeh¹²,Ebrahimi Marzieh²,Baharvand Hossein²³,Haeri Azadeh¹⁴,Shekari Faezeh²⁵

Affiliation:

1. Department of Pharmaceutics and Pharmaceutical Nanotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2. Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran

3. Department of Developmental Biology, School of Basic Sciences and Advanced Technologies in Biology, University of Science and Culture, Tehran, Iran

4. Protein Technology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

5. Advanced Therapy Medicinal Product Technology Development Center (ATMP-TDC), Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran

Funder

Royan Institute for Stem Cell Biology and Technology

Shahid Beheshti University of Medical Sciences

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10837450.2024.2384448

Reference48 articles.

1. Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?

2. Specific Targeting of PEGylated Liposomal Doxorubicin (Doxil®) to Tumour Cells Using a Novel TIMP3 Peptide

3. Recent Preclinical and Clinical Progress in Liposomal Doxorubicin

4. Physicochemical Biomolecular Insights into Buffalo Milk-Derived Nanovesicles

5. Indocarbocyanine nanoparticles extravasate and distribute better than liposomes in brain tumors